A New Year, a New Chapter for the DISCLOSE Trial

We are pleased to close the first year of the DISCLOSE Trial, having successfully randomized 40 participants across two centers: Tampere University Hospital and Viborg Regional Hospital, following the start of recruitment in August.

We are now excited to move into the next phase of the trial. Five new centers are ready to begin recruitment: Tartu University Hospital, Helsinki University Hospital, Kuopio University Hospital, Oulu University Hospital, and Hämeenlinna Central Hospital.

We look forward to continued collaboration and progress as the DISCLOSE Trial enters its second year.